Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#PH Health ×

Regulatory Updates

Aug 30, 2026•1 min read

FDA Approves ORSYTHIA (ANDA077099) Oral Tablet

FDA has approved ANDA077099 for ORSYTHIA, an oral tablet containing ethinyl estradiol 0.02 mg and levonorgestrel 0.1 mg, sponsored by PH Health.